Our Objectives

Our Objectives

LuCE aims to raise awareness about inequities regarding the access to lung cancer treatment and care in Europe. Moreover, it advocates European policies that will lead to improvements in lung cancer prevention, early detection, treatment and care.

Read More

Our Members

Our Members

Lung Cancer Europe provides a European platform for national lung cancer patient advocacy groups and supports the establishment of those groups in countries where such groups do not yet exist. Our member organisations and associate members come from all over Europe.

Read More

Our Diagnosis

Our Diagnosis

Lung cancer is literally the biggest cancer killer worldwide – causing more deaths than breast and prostate cancer put together all over the world. Read more about our diagnosis, types and stages of lung cancer, treatments and clinical trials, but also how to cope with lung cancer.

Read More

LUCE WEBINAR: ESMO 2020 lung cancer highlights

Lung Cancer Europe (LuCE) held a webinar on ESMO 2020 lung cancer highlights. The webinar was given by Professor Sanjay Popat FRCP PhD, Consultan Medical Oncologist, Royal Marsden Hospital and Professor of Thoracic Oncology, The Institute of Cancer Research in London, UK. The webinar was held and recorded on 15th October 2020

Read More

LuCE Webinar on ESMO 2020 lung cancer highlights

Lung Cancer Europe (LuCE) is holding a webinar on Thursday, 15th October 4PM CET with the aim of providing the latest updates and highlights in the treatment and diagnosis of lung cancer presented at the European Society of Medical Oncology (ESMO) Congress held in September 2020. The webinar is intended for an audience of advocates, patients and caregivers. It will […]

Read More

Pan-European survey of patient perception of unmet need and value drivers in NSCLC

A pan-European survey is being conducted with the aim to understand the following about people’s experience with non-small cell lung cancer (NSCLC), with the overall aim of better understanding experience during the care pathway, as well as needs and expectations in terms of innovative treatments. More specifically, the survey will explore:  perception of the disease burden on the daily life […]

Read More